Prostate Cancer Canada reminds men that early detection using ‘Smart Screening’ for prostate cancer can save lives
Toronto, ON – October 27, 2014 – Prostate Cancer Canada responds today to guidelines released from The Canadian Task Force on Preventive Health Care (CTFPHC) recommending that the Prostate Specific Antigen (PSA) test should be eliminated as a screening tool for prostate cancer. Prostate Cancer Canada disagrees with the recommendations and wants to remind Canadians that when performed appropriately, the benefits of PSA screening far outweigh the negatives. According to new research based on modelling estimates, if PSA testing was eliminated, the cases of advanced (metastatic) prostate cancer would double, resulting in an estimated 13-20 per cent increase in prostate cancer deaths annually.[i]
Prostate Cancer Canada Supports Innovation with Awarding of Movember Discovery Grants
Toronto, ON – Aug 14, 2014 – As part of our ongoing strategic commitment to prostate cancer research, Prostate Cancer Canada (PCC) is proud to announce the recipients of the 2014 Movember Discovery Grants, awarded by PCC, funded by Movember. This program allows both junior investigators at the start of their research careers and more established investigators to pursue important new directions in prostate cancer research. Each recipient of the Movember Discovery Grant will receive up to $200,000 in funding over a two-year term.
Prostate Cancer Canada awards $5 million in Movember funds
Toronto, ON – July 15, 2014 – Prostate Cancer Canada (PCC) is proud to announce the recipients of the $5 million 2014 Movember Team Grant. The grant, awarded by PCC and funded by Movember, rewards innovation and collaboration in a single research team from a variety of institutions across Canada.